GlassScriptPhysician profile
Sharon L Mcnutt
NPI 1447201264
$2,360.55
in general payments reported to CMS, 2019-2025
18 companies · $526 in 2025
The $526 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $197 · 2022: $440 · 2023: $583 · 2024: $615 · 2025: $526.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,623 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,622.87 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $422.42 | 2023-2025 | Tremfya, Stelara, Simponi Aria |
| Sun Pharmaceutical Industries INC. | $407.48 | 2022-2025 | Odomzo, Blu-U, Absorica Ld |
| Novartis Pharmaceuticals Corporation | $361.71 | 2021-2025 | |
| Abbvie INC. | $165.66 | 2021-2025 | |
| Lilly USA, LLC | $161.74 | 2022-2025 | Taltz, Olumiant, Ebglyss |
| Incyte Corporation | $133.75 | 2021-2024 | Opzelura |
| Genentech USA, INC. | $129.83 | 2021-2023 | Erivedge |
| Amgen INC. | $127.76 | 2023-2025 | Otezla, Otezla |
| Ucb, INC. | $91.10 | 2024-2025 | Bimzelx |
| Genzyme Corporation | $67.73 | 2021-2025 | |
| Pfizer INC. | $57.69 | 2022-2024 | |
| Boston Scientific Corporation | $49.75 | 2023-2024 | Wavewriter Alpha Prime 16 |
| Helsinn Therapeutics (U.S.), INC. | $49.40 | 2022-2023 | Valchlor |
| Biofrontera INC. | $38.13 | 2024 | Ameluz, Xepi, Bf-Rhodoled |
| Mayne Pharma Commercial LLC | $37.95 | 2023-2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lnhc, INC | $20.20 | 2025 | Zelsuvmi |
| Leo Pharma INC. | $19.47 | 2023 | Adbry |
| Epi Health, LLC | $18.78 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sharon Mcnutt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.